Dr Julie Fox

BRCCH Collaborator
Kings College London & Guys and St Thomas’ NHS Trust

Dr Julie Fox qualified from the University of Manchester and trained in Genitourinary Medicine at Imperial College London. Julie leads the HIV clinical trials unit at Guys and St Thomas’ NHS Trust and is a Reader in HIV Infection in the School of Immunology & Microbial Sciences at King's. Julie is Chief Investigator on national and international multi-centre intervention studies collaborating with NHS/academic partners across the UK, Europe and Sub-Saharan Africa.

Her research focuses on HIV prevention (vaccine and pre-exposure prophylaxis), HIV cure and optimising HIV treatment. She collaborates widely and is a keen proponent of multidisciplinary research. Julie is co-founder of the UK HIV cure group: Collaborative HIV Eradication of Reservoirs: UK BRC (CHERUB) and leads the EDCTP funded international combined HIV adolescent prevention group, CHAPS which focuses on HIV preventionin young adults in South Africa, Uganda and Zimbabwe. Furthermore, she is trial physician of the EDCTP funded international HIV vaccine and PrEP study, PREPVACC which is taking place in Uganda, South Africa, Tanzania and Mozambique.

Recently Julie has carried out SARS-CoV-2 research and is lead of the EDTP funded COVAB group which is a multidisciplinary research network across UK, Uganda and South Africa evaluating SARS-CoV-2 antibody evolution, developing a SARS-CoV-2 ex vivo challenge model and carrying out public engagement in rural communities (COVAB). She is Chief investigator of the COV-TT test and treat study and is collecting longitudinal samples from special populations to evaluate antibody response to vaccination (COVAB-B). In addition, she co-leads the HIV group of the Oxford COV002 astra zenica vaccine trial.


The latest updates from BRCCH